Schrank, Z.; Chhabra, G.; Lin, L.; Iderzorig, T.; Osude, C.; Khan, N.; Kuckovic, A.; Singh, S.; Miller, R.J.; Puri, N.
Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance. Cancers 2018, 10, 224.
https://doi.org/10.3390/cancers10070224
AMA Style
Schrank Z, Chhabra G, Lin L, Iderzorig T, Osude C, Khan N, Kuckovic A, Singh S, Miller RJ, Puri N.
Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance. Cancers. 2018; 10(7):224.
https://doi.org/10.3390/cancers10070224
Chicago/Turabian Style
Schrank, Zachary, Gagan Chhabra, Leo Lin, Tsatsral Iderzorig, Chike Osude, Nabiha Khan, Adijan Kuckovic, Sanjana Singh, Rachel J. Miller, and Neelu Puri.
2018. "Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance" Cancers 10, no. 7: 224.
https://doi.org/10.3390/cancers10070224
APA Style
Schrank, Z., Chhabra, G., Lin, L., Iderzorig, T., Osude, C., Khan, N., Kuckovic, A., Singh, S., Miller, R. J., & Puri, N.
(2018). Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance. Cancers, 10(7), 224.
https://doi.org/10.3390/cancers10070224